Stock Price
1,147.00
Daily Change
11.50 1.01%
Monthly
2.46%
Yearly
14.41%
Q2 Forecast
1,042.08

EPS Reference Time Actual Consensus Previous
2026-05-13 FY2026Q4 AM 26.43 16.32 1.93
2026-02-10 FY2026Q3 AM 2.30 16.63 12.34
2025-11-14 FY2026Q2 AM 13.07 17.95 17.89
2025-08-08 FY2026Q1 AM 11.16 18.26 16.77
2025-05-14 FY2025Q4 AM 1.93 12.39 -16.89



Peers Price Chg Day Year Date
Toyobo 1,714.00 43.00 2.57% 92.58% May/26
Teijin 1,600.00 -30.00 -1.84% 39.74% May/26
Toray Industries 1,147.00 11.50 1.01% 14.41% May/26
Kuraray 1,600.00 -19.00 -1.17% -10.76% May/26
Asahi Kasei 1,750.50 -19.50 -1.10% 74.35% May/26
Sumco 3,354.00 -73.00 -2.13% 250.58% May/26
Oji Paper 770.70 -5.10 -0.66% 13.76% May/26
Resonac Holdings 19,070.00 -380.00 -1.95% 546.44% May/26
Sumitomo Chemical 593.40 -9.60 -1.59% 77.19% May/26
Nissan Chemical 7,372.00 76.00 1.04% 71.44% May/26

Indexes Price Day Year Date
JP225 65376 -162.10 -0.25% 73.30% May/26

Toray Industries traded at 1,147.00 this Tuesday May 26th, increasing 11.50 or 1.01 percent since the previous trading session. Looking back, over the last four weeks, Toray Industries gained 2.46 percent. Over the last 12 months, its price rose by 14.41 percent. Looking ahead, we forecast Toray Industries to be priced at 1,042.08 by the end of this quarter and at 921.97 in one year, according to Trading Economics global macro models projections and analysts expectations.

TORAY INDUSTRIES, INC. is a diversified group. The Company operates in five business segments. The Textile segment manufactures, processes and sells textile and apparel products. The Functional Chemicals Segment manufactures and sells resins and resin molded products, films and film processed products, synthetic fiber plastic raw materials, fine chemicals, electronic information materials and imprint materials. The Carbon Fiber Composite Material segment provides carbon fiber, the same composite material and the same molded product. Environmental engineering segment undertakes comprehensive engineering, among others. The Life Science segment manufactures and sells pharmaceuticals and medical devices. The Company is also engaged in the service-related business, such as analysis, survey, and research.